We assessed the level of expression of miR-370 and SLD5 by qRT-PCR using tumor tissue on day 20 after treatment, and confirmed overexpression of miR-370 and downregulation of SLD5 in tumors from the miR-370-injected group. This evidence concerns the gene GINS4 and neoplasm.